Bent Frandsen
Director Ejecutivo en EXPRES2ION BIOTECH HOLDING AB .
Cargos activos de Bent Frandsen
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| EXPRES2ION BIOTECH HOLDING AB | Director Ejecutivo | 20/12/2019 | - |
| Contacto de Relaciones con Inversores | 01/01/2016 | - | |
| Corporate Officer/Principal | 01/01/2016 | 20/12/2019 | |
| Adaptvac ApS | Director/Miembro de la Junta | 01/01/2017 | - |
ExpreS2ion Biotechnologies ApS
 ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology ExpreS2ion Biotechnologies ApS operates as a biotechnology company which engages in the field of protein production in Drosophila Schneider-2 cells. Its services include custom proteins and research & development reagents, process development, and feasibility studies. The company was founded by Charlotte Dyring, Martin Roland Jensen, and Willem Adriaan de Jongh in 2009 and is headquartered in Horsholm, Denmark. | Director Ejecutivo | - | - |
Historial de carrera de Bent Frandsen
Antiguos cargos conocidos de Bent Frandsen.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
NsGene A/S
 NsGene A/S Pharmaceuticals: MajorHealth Technology NsGene A/S identifies neurotrophic proteins with therapeutic effects in the nervous system. It is a biotechnology company that focuses primarily on neurodegenerative disorders. The firm provides technologies that target protein therapeutics across the blood-brain-barrier and directly to diseased nerve cells. It develops therapeutic products for multiple indications with high medical needs including Alzheimer’s disease, Parkinson's disease, deafness, neuropathic pain, epilepsy, cortico-basal degeneration, and Huntington’s disease. The company was founded by Lars Ulrik Wahlberg and Teit Eliot Johansen in 1999 and is headquartered in Ballerup, Denmark. | Corporate Officer/Principal | - | - |
Formación de Bent Frandsen.
| Copenhagen Business School | Graduate Degree |
Estadísticas
Internacional
| Dinamarca | 6 |
Operativa
| Corporate Officer/Principal | 2 |
| Chief Executive Officer | 2 |
| Investor Relations Contact | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| EXPRES2ION BIOTECH HOLDING AB | Health Technology |
| Empresas privadas | 3 |
|---|---|
NsGene A/S
NsGene A/S Pharmaceuticals: MajorHealth Technology NsGene A/S identifies neurotrophic proteins with therapeutic effects in the nervous system. It is a biotechnology company that focuses primarily on neurodegenerative disorders. The firm provides technologies that target protein therapeutics across the blood-brain-barrier and directly to diseased nerve cells. It develops therapeutic products for multiple indications with high medical needs including Alzheimer’s disease, Parkinson's disease, deafness, neuropathic pain, epilepsy, cortico-basal degeneration, and Huntington’s disease. The company was founded by Lars Ulrik Wahlberg and Teit Eliot Johansen in 1999 and is headquartered in Ballerup, Denmark. | Health Technology |
| Adaptvac ApS | |
ExpreS2ion Biotechnologies ApS
ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology ExpreS2ion Biotechnologies ApS operates as a biotechnology company which engages in the field of protein production in Drosophila Schneider-2 cells. Its services include custom proteins and research & development reagents, process development, and feasibility studies. The company was founded by Charlotte Dyring, Martin Roland Jensen, and Willem Adriaan de Jongh in 2009 and is headquartered in Horsholm, Denmark. | Health Technology |
- Bolsa de valores
- Insiders
- Bent Frandsen
- Experiencia
